29 September 2003
Drug Development, Genentech Style
Drug Development, Genentech Style
“Its promising colon cancer fighter Avastin is a prime example of how the biotech ‘keeps following the science’”
Biotech Blog
Drug Development, Genentech Style
“Its promising colon cancer fighter Avastin is a prime example of how the biotech ‘keeps following the science’”
Yali Friedman lives in Washington, DC and is author of Building Biotechnology. He is also founder of DrugPatentWatch.com, and has a long history in biotechnology media. read more…
